Under the terms of the five-year deal, Butler has agreed to a minimum purchase of 20,000 units during the first year, such minimum purchase increasing each year culminating in 100,000 units during the fifth year.
Glucose RapidSpray, a liquid spray that is absorbed by the inner lining of the mouth without any chewing or swallowing, is designed to provide additional dietary glucose to dogs and cats with diabetes mellitus. The product may also be used to combat lethargy or first signs of low blood sugar, according to Generex Biotechnology.
“Although originally designed for people seeking additional glucose in their diets, we are pleased that the product has additional applications in the animal health industry,” said Rose Perri, chief operating officer of the Ontario-based company. “We extend credit to our business development and marketing team for their ingenuity in seeking other viable markets for our product pipeline.”